Ma Dan, Yu Dan
Department of Rehabilitation Medicine, West China Second University Hospital of Sichuan University, Chengdu 610041, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Nov;20(11):930-933. doi: 10.7499/j.issn.1008-8830.2018.11.010.
Mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase deficiency (HMCSD) is caused by HMGCS2 gene mutation. This paper reports the clinical and genetic features of an infant with this disease. The 8-month-old female infant was admitted to the hospital with diarrhea for 1 week and fever and convulsion for 1 day. The child presented with seizures, acidosis, hypoglycemia, abnormal liver function, myocardial injury and coagulation dysfunction. The new homozygous mutation c.1502G>A(p.R501Q) in the HMGCS2 gene was found in the infant by genetic testing. The mutant gene was found to be harmful by bioinformatics software analysis. Urine organic acid analysis indicated that 4-hydroxy-6-methyl-2-pyranone was significantly increased, which was consistent with the results of genetic testing. The infant was definitely diagnosed with HMCSD.
线粒体3-羟基-3-甲基戊二酰辅酶A合酶缺乏症(HMCSD)由HMGCS2基因突变引起。本文报道了一名患此病婴儿的临床和遗传特征。该8个月大女婴因腹泻1周、发热伴惊厥1天入院。患儿出现惊厥、酸中毒、低血糖、肝功能异常、心肌损伤及凝血功能障碍。通过基因检测在该婴儿中发现了HMGCS2基因新的纯合突变c.1502G>A(p.R501Q)。经生物信息学软件分析,发现该突变基因具有危害性。尿有机酸分析表明4-羟基-6-甲基-2-吡喃酮显著增加,这与基因检测结果一致。该婴儿被明确诊断为HMCSD。